In cancer biology, the overexpression of CAD, the multifunctional enzyme complex that includes DHOase, has been linked to poor prognosis in aggressive cancers such as glioblastoma [17,24] and hepatocellular carcinoma [25,26,27,28,29]. Here, CAD is linked to hepatocellular carcinoma.